SCHEMBL9011883

SCHEMBL9011883

CCCCCCCCCCCCCCC(CCC)S(=O)(=O)O

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.50
GPR84 Q9NQS5 7/20 0.42
FDPS P14324 3/20 0.42
FFAR1 O14842 1/20 0.42
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
LCK P06239 1/20 0.41
PPARD Q03181 1/20 0.41
ZDHHC20 Q5W0Z9 1/20 0.41
ZDHHC2 Q9UIJ5 1/20 0.41
CA2 P00918 3/20 0.39
CA1 P00915 2/20 0.39
LAP3 P28838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3426182 1.00 TP53 (0.50) TP53GPR84FDPSFFAR1LMNA
SCHEMBL28382455 1.00 TP53 (0.50) TP53GPR84FDPSFFAR1LMNA
SCHEMBL1992207 1.00 TP53 (0.50) TP53GPR84FDPSFFAR1LMNA
SCHEMBL7134938 1.00 TP53 (0.50) TP53GPR84FDPSFFAR1LMNA
SCHEMBL9660948 0.98 TP53 (0.48) TP53GPR84FDPSFFAR1LMNA
SCHEMBL8609916 0.98 TP53 (0.48) TP53GPR84FDPSFFAR1LMNA
SCHEMBL8813654 0.98 TP53 (0.52) TP53GPR84FDPSFFAR1LMNA
SCHEMBL28084442 0.96 TP53 (0.47) TP53GPR84FDPSFFAR1LMNA
SCHEMBL9460109 0.96 TP53 (0.54) TP53GPR84FDPSFFAR1LMNA
SCHEMBL6128322 0.96 TP53 (0.54) TP53GPR84FDPSFFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5559098-A Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic ROEHM PHARMA GMBH (DE) 1996-09-24 US disclosed
US-5476843-A Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic ROEHM PHARMA GMBH (DE) 1995-12-19 US disclosed